Medicare Benefits Schedule - Item 73343

Search Results for Item 73343

Category 6 - PATHOLOGY SERVICES

73343

73343 - Additional Information

Item Start Date:
01-Sep-2017
Description Updated:
01-Sep-2020
Schedule Fee Updated:
01-Sep-2017

Group
P7 - Genetics

Detection of 17p chromosomal deletions by fluorescence in situ hybridisation, in a patient with relapsed or refractory chronic lymphocytic leukaemia or small lymphocytic lymphoma, on a peripheral blood or bone marrow sample, requested by a specialist or consultant physician, to determine if the requirements for access to idelalisib, ibrutinib, venetoclax or acalabrutinib on the Pharmaceutical Benefits Scheme are fulfilled.

Fee: $230.95 Benefit: 75% = $173.25 85% = $196.35


Legend

  • Assist - Addition/Deletion of (Assist.)
  • Amend - Amended Description
  • Anaes - Anaesthetic Values Amended
  • Emsn - EMSN Change
  • Fee - Fee Amended
  • Renum - Item Number Change (renumbered)
  • New - New Item
  • NewMin - New Item (previous Ministerial Determination)
  • Qfe - QFE Change